E.U. and U.K. fighting over scarce vaccines

27 January 2021 - As vaccine production falls behind schedule, and the European Union lags in inoculating people, Brussels and London ...

Read more →

Alberta announces funding for pricey gene therapy drug Zolgensma

Alberta Health Minister Tyler Shandro announced funding Wednesday for the gene therapy Zolgensma, which is used to treat toddlers with ...

Read more →

On the role of cost effectiveness thresholds in health care priority setting

25 January 2021 - In the past few years, empirical estimates of the marginal cost at which health care produces a ...

Read more →

NICE publishes final guidance on new use for Lonsurf

27 January 2021 - NICE has completed its review of trifluridine with tipiracil hydrochloride for the treatment of patients with ...

Read more →

EU demands UK made AstraZeneca vaccine doses

27 January 2021 - The EU has urged pharmaceutical firm AstraZeneca to supply it with more doses of its COVID-19 ...

Read more →

European Medicines Agency accepts GBT’s marketing authorisation application for Oxbryta (voxelotor) for the treatment of haemolytic anemia in sickle cell disease

27 January 2021 - Global Blood Therapeutics today announced that the EMA has completed the validation of GBT’s marketing authorisation application ...

Read more →

Coronavirus: EU threat to Australia’s vaccine program

27 January 2021 - A European move to shore up supplies of both the Pfizer/BioNTech and Oxford/AstraZeneca vaccines looks to ...

Read more →

Australia’s COVID-19 vaccine information campaign begins

27 January 2021 - The Australian Government’s $23.9 million public information campaign to encourage Australians to get a COVID-19 vaccine begins ...

Read more →

Government rejects claim overseas production issues threaten access to vaccines

27 January 2021 - The entire population could be vaccinated against COVID-19 in as little as 6½ months, meaning it's ...

Read more →

European Commission approves Keytruda (pembrolizumab) as first-line treatment in adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer

26 January 2021 - Keytruda is first checkpoint inhibitor approved in Europe to treat MSI-H or dMMR colorectal cancer. ...

Read more →

NICE recommends Revlimid for newly diagnosed multiple myeloma patients

27 January 2021 - Bristol Myers Squibb’s Revlimid (lenalidomide) has received a recommendation from the UK’s NICE for newly diagnosed ...

Read more →

Will Canadians get to choose which COVID-19 vaccine they get?

26 January 2021 - Two vaccines are already approved, two are under review, and two more are in the pipeline, ...

Read more →

Alleviant Medical receives breakthrough device designation from FDA for transcatheter technology

25 January 2021 - Alleviant Medical today announced that the US FDA has granted the company a breakthrough device designation ...

Read more →

PEDRA Technology receives FDA breakthrough device designation for its PEDRA Xauron real-time tissue perfusion system

25 January 2021 - Novel perfusion monitor achieves FDA breakthrough device Designation for real-time, peri-procedural monitoring of tissue perfusion in patients ...

Read more →

Scott Morrison says Australia will not be a hostage to global vaccine shortages

26 January 2021 - Scott Morrison has revealed why Australia won’t be “completely hostage” to overseas vaccine schedules and shortages. ...

Read more →